Skip to content

Informed Choice - Compass

Informed Choice Intervention for Colorectal Cancer Screening: Compass

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05246839
Enrollment
1823
Registered
2022-02-18
Start date
2022-04-28
Completion date
2025-01-31
Last updated
2025-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Keywords

CRC Screening, Colonoscopy, FIT, Cologuard, Screening Modality, Survey, Video, sDNA-FIT

Brief summary

The primary objective of this study is to evaluate the impact of a theoretically grounded video that includes information about CRC screening modality choices on CRC screening rates and time adherent to CRC guidelines. The results will not be posted because the study terminated early and the primary endpoint was not analyzed.

Detailed description

Participants 45 to 70 years of age, scheduled for a primary care (index) appointment, at average risk for colorectal cancer (CRC), and due for CRC screening will be enrolled in the study. Participants will be randomized to one of three intervention arms: no video (arm 1), brief CRC screening video (arm 2), or enhanced CRC screening video (arm 3). Participants in all intervention arms will complete surveys regarding intention to screen for CRC and preference for screening modality prior to viewing the video, after the video, and after their index appointment. Participants will be surveyed, and medical information collected, for 1 year after randomization to assess adherence to CRC screening and CRC screening outcomes.

Interventions

BEHAVIORALBrief Video

Videos about colorectal cancer screening.

BEHAVIORALBrief Video Plus

Videos about colorectal cancer screening and modalities.

Sponsors

Mayo Clinic
CollaboratorOTHER
University of Utah
CollaboratorOTHER
American Cancer Society, Inc.
CollaboratorOTHER
F!ght Colorectal Cancer
CollaboratorUNKNOWN
Exact Sciences Corporation
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
45 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

1. Participant is 45 to 70 years of age, inclusive. 2. Participant presents for a primary care appointment. 3. Participant understands the study procedures and can provide informed consent to participate in the study and authorization for release of relevant protected health information (PHI) to the study Investigator. 4. Participant has never been screened for CRC.

Exclusion criteria

1. Participant has symptoms or signs that require immediate, or near-term referral for diagnostic or therapeutic colonoscopy. 2. Participant is due for CRC screening within three months and is already scheduled for colonoscopy. 3. Participant has a personal history of CRC or colonic adenomatous or sessile serrated polyps. 4. Participant has a personal history of inflammatory bowel disease. 5. Participant has a family history of CRC in at least one first- or second-degree relative diagnosed prior to age 60 and/or at least 2 first-degree relatives diagnosed with CRC at any age. 6. Participant has a personal diagnosis or family history of any of the following conditions: 1. Familial adenomatous polyposis (also referred to as FAP, including attenuated FAP and Gardner's syndrome), 2. Hereditary non-polyposis CRC syndrome (also referred to as HNPCC or Lynch Syndrome), 3. Other hereditary cancer syndromes including, but are not limited to Peutz-Jeghers Syndrome, MYH-Associated Polyposis (MAP), Turcot's (or Crail's) Syndrome, Cowden's Syndrome, Juvenile Polyposis, Neurofibromatosis, or Familial Hyperplastic Polyposis. 7. Participant has a diagnosis of Cronkhite-Canada Syndrome. 8. Participant is current with CRC screening, including gFOBT or FIT within the preceding 12 months, Cologuard within the preceding 3 years, flexible sigmoidoscopy or CT colonography within the preceding 5 years, or colonoscopy within the preceding 10 years. Participants can be enrolled up to 3 months prior to screening due date. 9. Participant has any condition that in the opinion of the Investigators should preclude participation in the study, including comorbid illnesses precluding endoscopic evaluation or that limit life expectancy to less than 10 years.

Design outcomes

Primary

MeasureTime frameDescription
Impact of Brief Videos1 yearTo evaluate the impact of a theoretically grounded video that includes information about CRC screening modality choices (colonoscopy, FIT, and Cologuard) on CRC screening rates and the proportion of time adherent to CRC guidelines.

Secondary

MeasureTime frameDescription
Participant Screening Preferences1 yearTo examine initial mode preferences between participants viewing a theoretically grounded video that includes information about CRC screening modality choices (colonoscopy, FIT, and Cologuard) compared to those receiving only a brief informational video about CRC screening or receiving only usual care.

Other

MeasureTime frameDescription
Exploratory Objective- Participant1 yearEvaluate participant knowledge, attitudes, and intentions related to CRC screening and assess personal and environmental factors associated with screening intentions and completion by modality.
Exploratory Objective- Provider1 yearCharacterize provider, system, and site-level factors associated with CRC screening rates and use of various screening modalities at different times throughout the intervention (prior to and after recruitment is completed).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026